| Oct 12, 2023 |
Medtronic Receives CE Mark for Evolut™ FX TAVI System for Treatment of Severe Aortic Stenosis |
| May 1, 2023 |
Medtronic Receives FDA Approval For Its Next Generation Micra Leadless Pacing Systems |
| Mar 5, 2023 |
Three-Year Results of Medtronic's Evolut TAVR Compared to Surgery in Low Risk Patients
Presented at ACC |
| Feb 27, 2023 |
Medtronic CoreValve/Evolut™ Demonstrates Best Durability |
| Feb 1, 2023 |
Medtronic Continues to Make Significant Advances as an Inclusion, Diversity & Equity Leader |
| Jan 11, 2023 |
Medtronic Announces First Enrollment in Head-to-Head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair |
| Dec 5, 2022 |
Medtronic Completes Enrollment in Pivotal Trial Evaluating First-Of-Its-Kind Pulsed Field Ablation Catheter for Patients with Atrial Fibrillation |
| Nov 29, 2022 |
Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting |
| Nov 7, 2022 |
SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with Other SPYRAL HTN Renal Denervation Trials |
| Nov 2, 2022 |
Clinical Studies Show Medtronic Drug Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World |
| Sep 21, 2022 |
Medtronic is the First and Only Company to Receive FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-Eluting Stent |
| Sep 20, 2022 |
Medtronic Receives FDA Clearance for Expanded Indication of LINQ II™ Insertable Cardiac Monitor for Use in Pediatric Patients Ages 2 and Older |
| Sep 18, 2022 |
TCT 2022: SYMPLICITY HTN-3 Trial Data Show Sustained Long-Term Blood Pressure Reductions With Medtronic Renal Denervation Procedure |
| Sep 16, 2022 |
Medtronic Announces Full Market Launch in U.S. of Evolut™ Fx Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis |
| Jul 12, 2022 |
Medtronic Announces Co-promotion Agreement with CathWorks, with Path Toward Acquisition |
| May 27, 2022 |
Medtronic Low-Profile Drug-Coated Balloon Platform Receives U.S. FDA Approval to Treat Peripheral Arterial Disease |
| May 17, 2022 |
Optimized Procedure and Care Pathway with Medtronic Evolut™ TAVR System Demonstrates Excellent Valve Performance and Procedural Outcomes |
| May 17, 2022 |
EuroPCR: Medtronic Renal Denervation System Shows Better Blood Pressure Control with Significantly More Time in Target Range |
| May 13, 2022 |
Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent System |
| May 2, 2022 |
Medtronic Announces First Enrollment in Pivotal Trial of Patients with Moderate, Symptomatic Aortic Stenosis |
| Apr 27, 2022 |
IN.PACT™ AV Drug-Coated Balloon First and Only to Show Sustained and Superior Performance Compared to PTA Through 36 Months |
| Apr 25, 2022 |
Medtronic Names New Chief Scientific, Medical, and Regulatory Officer |
| Apr 4, 2022 |
Medtronic TAVR Platform First and Only To Demonstrate Durability Benefit Over SAVR At 5 Years |
| Sep 28, 2021 |
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio |
| Jul 26, 2021 |
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease |
| May 18, 2021 |
Medtronic Evolut™ TAVR System Shows Strong Performance at Two Years in Low Risk Trial |
| May 3, 2021 |
Medtronic Announces CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe |
| Mar 26, 2021 |
Medtronic Receives FDA Approval for "Breakthrough" Transcatheter Pulmonary Valve Replacement for Patients with Congenital Heart Disease |
| Oct 1, 2020 |
Medtronic Resolute Onyx™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients |
| Jun 16, 2020 |
ABRE Study Meets Primary Safety and Effectiveness Endpoints |
| Jun 5, 2020 |
Medtronic Resolute Onyx™ DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe |
| May 18, 2020 |
Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses |
| Mar 18, 2020 |
Medtronic Continuing to Increase Ventilator Production to Address COVID-19 Pandemic |
| Feb 4, 2020 |
Medtronic Begins New Pilot Study as Part of SPYRAL HTN Clinical Program for Renal Denervation in Hypertension Patients |
| Sep 23, 2019 |
Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients |
| Sep 7, 2019 |
IN.PACT AV Access Trial Meets Primary Safety and Effectiveness Endpoints |
| Aug 16, 2019 |
Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality |
| Mar 16, 2019 |
Medtronic Evolut Low Risk Trial Meets Primary Endpoint |
| Jan 30, 2019 |
Medtronic Valiant™ Captivia™ Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients |
| Jan 15, 2019 |
Medtronic Launches Mobile App That Communicates Directly with World's First Smartphone-Connected Pacemakers |
| Nov 13, 2018 |
Medtronic Receives CE Mark Approval for the Valiant Navion™ Thoracic Stent Graft System |
| Nov 6, 2018 |
Medtronic Presents IN.PACT SFA Trial Five-Year Data and Total IN.PACT All-Subjects Analysis in VIVA Late Breaking Clinical Trials |
| Oct 23, 2018 |
Medtronic Receives FDA Approval for Valiant Navion™ Thoracic Stent Graft System |
| Sep 24, 2018 |
Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients |
| Sep 22, 2018 |
Medtronic Presents IN.PACT Global Study Three-Year Data and Total IN.PACT™ Imaging and Propensity Analyses |
| Aug 15, 2018 |
Medtronic Announces Commercial Launch of the IN.PACT™ Admiral™ Drug-Coated Balloon in Japan |
| Jun 15, 2018 |
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT™ Admiral™ Drug Coated Balloons |
| Apr 23, 2018 |
Medtronic IN.PACT™ Admiral™ Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions |
| Apr 5, 2018 |
Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics |
| Feb 26, 2018 |
Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels |
| Jan 30, 2018 |
IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis |
| Jan 26, 2018 |
Medtronic Launches IDE Study to Evaluate the Abre™ Venous Self-Expanding Stent System in Patients with Deep Venous Disease |
| Jan 24, 2018 |
Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant™ II/IIs Stent Graft System |
| Nov 2, 2017 |
Medtronic Evolut™ PRO TAVR System with Advanced Sealing Maintains Excellent Outcomes Over Time |
| Nov 1, 2017 |
Independent Study Shows New Data on Shortened DAPT in STEMI Patients with Medtronic Resolute Integrity Drug-Eluting Stent |
| Nov 1, 2017 |
Medtronic Unveils Strong Early Outcomes for the Intrepid™ Transcatheter Mitral Valve Replacement (TMVR) System |
| Jul 31, 2017 |
Medtronic Announces CE Mark and European Launch of CoreValve™ Evolut™ PRO Transcatheter Valve with Advanced Sealing |
| Jul 10, 2017 |
FDA Gives Approval to Medtronic's CoreValve for Use in Patients at Intermediate Risk for Surgical Valve Replacement |
| May 1, 2017 |
Medtronic Launches Resolute Onyx™ Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes |
| Mar 22, 2017 |
Medtronic Receives FDA Approval for CoreValve™ Evolut™ Pro Transcatheter Valve with Advanced Sealing |
| Mar 17, 2017 |
Landmark SURTAVI Clinical Trial Shows Transcatheter Aortic Valve Replacement (TAVR) with the Self-Expanding Platform Performs as Well as Surgery in Intermediate Risk Severe Aortic Stenosis Patients |
| Mar 10, 2017 |
Medtronic Announces Medicare Reimbursement for the First and Only Leadless Pacemaker Available for Use in the U.S. |
| Mar 9, 2017 |
Medtronic Launches Below-The-Knee Clinical Study in Europe for Treatment of PAD Using New Drug-Coated Balloon Technology |
| Feb 27, 2017 |
New Analysis of Reverse Trial Shows Medtronic CRT Devices Cost-Effective, While Helping Patients with Mild Heart Failure Live Longer |
| Feb 13, 2017 |
Medtronic Expands Coronary Portfolio to Include New DxTerity™ Diagnostic Catheters and Suite of Tools for the Transradial Approach |
| Feb 9, 2017 |
First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies |
| Feb 1, 2017 |
Medtronic CardioInsight Mapping Solution Cleared by FDA |
| Jan 24, 2017 |
Medtronic Announces CE Mark for New Lower Profile HawkOne 6F Directional Atherectomy System |
| Jan 17, 2017 |
Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies |
| Dec 6, 2016 |
Medtronic's Endurant™ II/IIs Stent Graft System Receives CE Mark for Use with ChEVAR Parallel Graft Technique |
| Dec 1, 2016 |
Medtronic Announces Reimbursement Approval and Launch of CoreValve™ Evolut™ R System in Japan |
| Nov 15, 2016 |
Medtronic's Endurant™ II/IIs Stent Graft System Delivers Positive Outcomes in Patients with Challenging Aortic Aneurysms |
| Nov 1, 2016 |
Medtronic Harmony™ Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year |
| Nov 1, 2016 |
Medtronic CoreValve™ Evolut R™ System Shows Exceptional Clinical Outcomes at One Year |
| Oct 31, 2016 |
First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes |
| Oct 31, 2016 |
New Data on Medtronic Evolut™ R TAVR System Show Excellent 'Real-World' Outcomes in Global Patient Population |
| Oct 30, 2016 |
Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity™ DES |
| Oct 26, 2016 |
Medtronic Announces FDA Approval of New Recaptureable TAVR System Available for Severe Aortic Stenosis Patients with Large Anatomies |
| Oct 24, 2016 |
Medtronic Receives FDA Clearance of New Lower Profile HawkOne 6F Directional Atherectomy System |
| Oct 13, 2016 |
Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging |
| Sep 20, 2016 |
Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years |
| Sep 19, 2016 |
New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy for the Medtronic In.Pact Admiral DCB |
| Sep 13, 2016 |
Medtronic Receives FDA Approval of First Drug-Coated Balloon for Treatment of In-Stent Restenosis (ISR) |
| Aug 29, 2016 |
Medtronic Technologies Improve Delivery of Cardiac Resynchronization Therapy |
| Aug 28, 2016 |
New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker |
| Aug 1, 2016 |
Medtronic CoreValve™ Evolut™ R System First TAVI to Receive CE Mark for Intermediate Risk Aortic Stenosis Patients |
| Apr 6, 2016 |
FDA Approves World's Smallest Pacemaker for U.S. Patients |
| Apr 3, 2016 |
Medtronic CoreValve® System Maintains Survival Advantages Over Surgery in High Risk Aortic Stenosis Patients at Three Years |
| Apr 3, 2016 |
Medtronic Announces Early Data and Completes Enrollment in CE Mark Cohort in Drug-Filled Stent Trial |
| Apr 2, 2016 |
Medtronic CoreValve® System Demonstrates Superior Survival to Surgery in Aortic Stenosis Patients with Lower STS Scores |
| Mar 7, 2016 |
Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve™ Evolut™ R System in 'Real-World' Setting |
| Feb 22, 2016 |
Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients |
| Feb 22, 2016 |
Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans |
| Feb 18, 2016 |
Meta-Analysis Shows Medtronic's Solitaire™ Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+ |
| Feb 9, 2016 |
First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study |
| Feb 5, 2016 |
Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators |
| Feb 1, 2016 |
Medtronic Adds New Resolute Onyx™ Drug-Eluting Stent Sizes and Expands Indications |
| Jan 29, 2016 |
Medtronic to Present Data on Micra® Transcatheter Pacing System at Upcoming FDA Advisory Committee Meeting |
| Jan 11, 2016 |
Medtronic IN.PACT Admiral DEB Receives CE Mark for Treatment of AV Access In Patients with End-Stage Renal Disease |
| Dec 14, 2015 |
Medtronic Announces New High-Tech Facility in Galway; Building on Global Synergies |
| Nov 17, 2015 |
Medtronic's Endurant AAA Stent Graft Delivers Durable, Consistent and Proven Outcomes at Four Years in Real-World Setting |
| Nov 16, 2015 |
Medtronic Showcases Aortic Leadership in Innovation with Clinical Release and Pipeline at VEITH 2015 |
| Nov 9, 2015 |
World's Smallest Pacemaker, Medtronic Micra® TPS, Meets Global Clinical Trial's Safety and Effectiveness Endpoints |
| Nov 2, 2015 |
REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease |
| Nov 2, 2015 |
IN.PACT Admiral Drug-Coated Balloon Cost-Effectiveness Study and Global Study Results of In-Stent Restenosis Population Highlighted in Late Breaking Clinical Trials at VIVA 2015 |
| Nov 2, 2015 |
Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015 |
| Oct 14, 2015 |
Medtronic CoreValve® Evolut® R System Demonstrates Exceptional Results at One Year |
| Oct 14, 2015 |
Medtronic Drug-Coated Balloon Sustains Superiority Over Balloon Angioplasty at Two Years in Patients with Peripheral Arterial Disease |
| Oct 13, 2015 |
Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations |
| Oct 12, 2015 |
Medtronic CoreValve® System Demonstrates Excellent Clinical Outcomes in First Report of 'Real-World' U.S. Experience |
| Oct 12, 2015 |
Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants |
| Oct 6, 2015 |
Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015 |
| Oct 5, 2015 |
Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years |
| Oct 2, 2015 |
Medtronic Completes Acquisition of Twelve, Inc. |
| Aug 31, 2015 |
Medtronic Acquires Medina Medical |
| Aug 31, 2015 |
Medtronic Study Detects Gene Associated with Sudden Cardiac Death |
| Aug 25, 2015 |
Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device |
| Aug 3, 2015 |
CMS Grants New Technology Add-On Payment for Inpatient Use of Medtronic's Drug-Coated Balloon |
| Jun 23, 2015 |
Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S. |
| Jun 20, 2015 |
Endurant AAA Stent Graft Maintains Durable, Consistent and Proven Outcomes for Abdominal Aortic Aneurysm Repair in Long-Term Follow-Up |
| Jun 10, 2015 |
Medtronic Initiates U.S. Launch of
Fortrex™ PTA Balloon |
| May 20, 2015 |
Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions |
| May 15, 2015 |
Global Clinical Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety and Performance Measures |
| May 14, 2015 |
Global Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety Measures in Wide Range of Patients |
| Apr 29, 2015 |
Endurant AAA Stent Graft System from Medtronic Delivers Consistently Strong Results in Abdominal Aortic Aneurysms with Short and Standard 'Neck' Lengths |
| Apr 21, 2015 |
Medtronic Begins Enrollment in Feasibility Study of Valiant 'Mona LSA' Branch Thoracic Stent Graft System |
| Apr 14, 2015 |
Medtronic Announces CE Mark of World's Smallest Pacemaker, Micra Transcatheter Pacing System |
| Apr 14, 2015 |
Medtronic to Develop Stent Graft System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms Under Exclusive Patent License Agreement with Sanford Health |
| Apr 9, 2015 |
Medtronic Initiates U.S. Launch of HawkOne™ Directional Atherectomy System for Treatment of Peripheral Arterial Disease |
| Apr 1, 2015 |
EverFlex™ Peripheral Stent from Medtronic Delivers Sustained Patency in Long, Complex Lesions |
| Apr 1, 2015 |
Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation |
| Mar 31, 2015 |
Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures |
| Mar 30, 2015 |
Medtronic Announces Japanese Regulatory Approval of CoreValve® System |
| Mar 15, 2015 |
Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years |
| Mar 14, 2015 |
Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical Results |
| Mar 14, 2015 |
Medtronic CoreValve® Evolut™ R System Yields Exceptional Outcomes in First Clinical Study |
| Mar 12, 2015 |
Medtronic Initiates Pivotal Studies of Resolute Onyx™ Drug-Eluting Stent in United States |
| Feb 19, 2015 |
Medicare Approves Transitional Pass-Through Payment for Outpatient Use of Medtronic Drug-Coated Balloon |
| Feb 16, 2015 |
Medtronic Announces CE Mark and European Launch of the Euphora™ Semicompliant Coronary Balloon Catheter |
| Feb 13, 2015 |
The American Heart Association - American Stroke Association and Medtronic Collaborate to Reduce Recurrent Strokes |
| Feb 11, 2015 |
Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients in 'Real-World' Study |
| Feb 4, 2015 |
Medtronic Starts U.S. Launch of IN.PACT Admiral Drug-Coated Balloon for Treatment of Peripheral Arterial Disease in Upper Leg |
| Feb 2, 2015 |
Medtronic Expands Access to the Next Generation CoreValve Evolut R System with New Valve Sizes |
| Jan 26, 2015 |
Medtronic Completes Acquisition of Covidien |
| Jan 26, 2015 |
Medtronic's Acquisition of Covidien Approved by Irish High Court; Anticipated to Close on January 26, 2015 |
| Jan 5, 2015 |
Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg |
| Dec 22, 2014 |
Medtronic Drug-Coated Balloon for Peripheral Artery Disease Tops Standard Balloon Angioplasty in Landmark Study |
| Dec 9, 2014 |
Endurant 'AAA' Stent Graft from Medtronic Continues to Deliver Durable, Consistent and Proven Outcomes |
| Nov 26, 2014 |
Medtronic Acquisition of Covidien Receives U.S. FTC Clearance |
| Nov 12, 2014 |
Medtronic Adds to Endurant 'AAA' Stent Graft System |
| Nov 4, 2014 |
Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study |
| Nov 3, 2014 |
Medtronic Launches Resolute Onyx™ Drug-Eluting Stent Following CE Mark |
| Oct 14, 2014 |
Medtronic Announces FDA Approval of Pacing Lead for Full-Body MRI Scans |
| Oct 13, 2014 |
Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access |
| Sep 17, 2014 |
Medtronic Elects Elizabeth Nabel to the Board of Directors |
| Sep 16, 2014 |
Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease |
| Sep 15, 2014 |
Medtronic Launches SEEQ™ Wearable Cardiac Monitoring System in United States |
| Sep 13, 2014 |
Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients |
| Sept 13, 2014 |
Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients |
| Sep 11, 2014 |
Medtronic NC Euphora™ Coronary Balloon Receives FDA Clearance |
| Sep 10, 2014 |
Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R |
| Sep 3, 2014 |
Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System |
| Sep 2, 2014 |
Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference |
| Jun 25, 2014 |
Study Published in The New England Journal of Medicine Finds Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients Better Than Standard Care |
| Jun 19, 2014 |
Medtronic Announces Preliminary Outcomes for World's Smallest Cardiac Pacemaker |
| Jun 12, 2014 |
Medtronic CoreValve® System Receives FDA Approval for Patients at High Risk for Surgery |
| Jun 11, 2014 |
Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease |
| Jun 4, 2014 |
Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market |
| May 21, 2014 |
Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study |
| May 20, 2014 |
Medtronic Announces CE Mark and Launch of NC Euphora™ Coronary Balloon |
| May 20, 2014 |
Medtronic Settles Global Patent Litigation with Edwards Lifesciences |
| May 20, 2014 |
Medtronic Reports Fourth Quarter and Fiscal Year 2014 Earnings |
| Apr 29, 2014 |
Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes |
| Apr 21, 2014 |
Federal Appeals Court Agrees to Medtronic Request to Postpone Injunction |
| Apr 19, 2014 |
Update on CoreValve Federal District Court Ruling; Court Agrees to Expedited Appeal |
| Apr 18, 2014 |
Endurant AAA Stent Graft from Medtronic Continues Exceptional Long-Term Performance in Observational Studies |
| Apr 11, 2014 |
Medtronic to Appeal Federal District Court Ruling |
| Apr 5, 2014 |
'IN.PACT Admiral' Drug-Coated Balloon From Medtronic Outperforms Standard Angioplasty In Landmark Study |
| Mar 31, 2014 |
Medtronic CoreValve® System Demonstrates Long-Term Durability |
| Mar 30, 2014 |
World's First Transcatheter Valve, Medtronic Melody® Transcatheter Pulmonary Valve Shows Positive Clinical Outcomes in Real-World Study |
| Mar 30, 2014 |
Medtronic Global SYMPLICITY Registry Shows Strong Safety Profile of the Symplicity™ Renal Denervation System |
| Mar 29, 2014 |
Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial |
| Mar 29, 2014 |
Medtronic Releases Results of SYMPLICITY HTN-3 |
| Mar 10, 2014 |
Medtronic Seeking Long-Distance Runners Who Benefit From Medical Technology |
| Mar 6, 2014 |
Medtronic Wins European Patent Office Ruling |
| Feb 19, 2014 |
Medtronic Announces Global Launch of Miniature Cardiac Monitor, Reveal LINQ™ ICM |
| Feb 18, 2014 |
Medtronic Reports Third Quarter Earnings |
| Feb 13, 2014 |
Medtronic Launches "TOTAL Across" Crossing Catheter in Europe |
| Feb 11, 2014 |
Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2014 |
| Jan 28, 2014 |
Medtronic Relocates Its Regional Headquarters to Dubai |
| Jan 28, 2014 |
Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections |
| Jan 17, 2014 |
Medtronic CoreValve® System Obtains Early FDA Approval on Exceptional Clinical Performance |
| Jan 15, 2014 |
Medtronic to Appeal Federal District Court Verdict |
| Jan 9, 2014 |
Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint |
| Dec 17, 2013 |
Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension |
| Dec 9, 2013 |
Medtronic Announces First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker |
| Dec 5, 2013 |
Medtronic Announces CE Mark and TGA Listing for the Symplicity Spyral™ Multi-Electrode Catheter and Symplicity G3™ Generator |
| Nov 25, 2013 |
Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting |
| Nov 20, 2013 |
Valiant 'Mona LSA' Stent Graft System from Medtronic Demonstrates Proof of Concept in Early Feasibility Study |
| Nov 14, 2013 |
Medtronic to Resume Sales of CoreValve System in Germany |
| Nov 5, 2013 |
Medtronic Announces FDA Approval to Enroll First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension |
| Oct 31, 2013 |
In Trial of Rivals, Medtronic's Resolute Integrity Stent Outperforms Promus Element Stent on Longitudinal Strength |
| Oct 31, 2013 |
In Studies of Medtronic Stents, Patients Who Interrupted Dual Antiplatelet Therapy Early Saw No Increased Thrombosis Risk |
| Oct 30, 2013 |
Medtronic CoreValve U.S. Pivotal Trial Affirms Benefits of Self-Expanding Transcatheter Aortic Valve Replacement in Patients Treated Via Alternative Access Routes |
| Oct 30, 2013 |
Medtronic Presents Three-Year Results From SYMPLICITY HTN-2 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity™ Renal Denervation System |
| Oct 29, 2013 |
Medtronic CoreValve U.S. Pivotal Trial Results Reveal Positive Outcomes for Patients |
| Oct 22, 2013 |
Medtronic Initiates Clinical Study of Recapturable CoreValve Evolut R |
| Oct 21, 2013 |
Medtronic Launches New Device To Remove Coronary Thrombus |
| Oct 17, 2013 |
Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013 |
| Sep 24, 2013 |
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries |
| Sep 15, 2013 |
Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant And Sustained Drops In Blood Pressure After Treatment With The Symplicity™ Renal Denervation System |
| Sep 2, 2013 |
Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity™ Renal Denervation System from the Global SYMPLICITY Registry |
| Aug 15, 2013 |
Medtronic Submits First 'PMA' Module for IN.PACT Admiral Drug-Eluting Balloon |
| Jul 12, 2013 |
Medtronic Issues Statement on Ruling in Germany |
| Jun 3, 2013 |
Medtronic Reaches Major Milestone in Clinical Program for 'IN.PACT Admiral' Drug-Eluting Balloon |
| May 31, 2013 |
Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneurysm Repair |
| May 30, 2013 |
Medtronic Garners First-Of-Its-Kind FDA Approval for 'AUI' Device with Endurant II AAA Stent Graft System |
| May 23, 2013 |
Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures |
| May 23, 2013 |
Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries |
| May 22, 2013 |
For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results |
| May 20, 2013 |
Medtronic Receives 'CE' Mark for 'Export Advance' Aspiration Catheter |
| Mar 14, 2013 |
With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis |
| Mar 7, 2013 |
Medtronic Submits IDE to FDA for U.S. Randomized Clinical Trial for Uncontrolled Hypertension Patients with Systolic Blood Pressure Between 140-160 mm Hg |
| Mar 6, 2013 |
Symplicity™ Renal Denervation System One of First Devices Accepted to Participate in Concurrent Review for Joint FDA Premarket Approval and Medicare National Coverage Determination |
| Mar 4, 2013 |
Medtronic Approved to Update Resolute Integrity Stent's 'CE' Mark Labeling on Dual Antiplatelet Therapy |
| Feb 28, 2013 |
Medtronic's Engager™ Transcatheter Aortic Valve Gets European Approval |
| Feb 25, 2013 |
FDA Approves Longer Lengths of Medtronic's Resolute Integrity Stent |
| Feb 19, 2013 |
Medtronic Reports Third Quarter Earnings; Drug-Eluting Stent Revenue Up 42% |
| Feb 13, 2013 |
Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System |
| Feb 11, 2013 |
Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2013 |
| Jan 24, 2013 |
Medtronic Launches Lower-Extremity Indication for Complete 'SE' Vascular Stent Internationally |
| Jan 23, 2013 |
Medtronic Drug-Eluting Balloon Study Completes Enrollment |
| Dec 17, 2012 |
One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation |
| Nov 19, 2012 |
Medtronic's Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair |
| Nov 13, 2012 |
FDA Approves Medtronic Stent Graft For Aortic Transection Repair |
| Oct 24, 2012 |
Medtronic Engages Cardiologists In 'World Diabetes Day' |
| Oct 23, 2012 |
Medtronic Stent Successfully Treats Long Lesions And Small Vessels, Two Characteristics Typical Of Patients With Diabetes, In Multiple Studies |
| Oct 22, 2012 |
Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year |
| Oct 22, 2012 |
Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients |
| Oct 22, 2012 |
New Study Results Show High Survival Rates And Improved Quality Of Life For Patients With Medtronic Corevalve® System |
| Oct 5, 2012 |
Medtronic Launches New Angioplasty Catheter for Below-the-Knee Arteries |
| Oct 5, 2012 |
Medtronic Completes Enrollment in Landmark Study of IN.PACT Drug-Eluting Balloon in Peripheral Artery Disease |
| Oct 3, 2012 |
Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension |
| Oct 2, 2012 |
New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve® System |
| Oct 1, 2012 |
Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan |
| Sep 26, 2012 |
Medtronic Gains CE Mark for CoreValve® Evolut™ 23mm Transcatheter Aortic Valve |
| Sep 21, 2012 |
Medtronic Commits $6 Million to Address Cardiovascular Disease, Diabetes Care for Underserved in India |
| Sep 12, 2012 |
Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension |
| Aug 29, 2012 |
Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial |
| Aug 28, 2012 |
Medtronic Launches Resolute Integrity Coronary Stent System in Japan |
| Aug 27, 2012 |
Medtronic Study Confirms Long-Term Safety of Drug-Eluting Coronary Stents |
| Jul 18, 2012 |
Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients |
| Jun 21, 2012 |
Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program |
| May 16, 2012 |
Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries |
| May 15, 2012 |
Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe |
| Apr 27, 2012 |
Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment |
| Apr 17, 2012 |
Medtronic Announces Global Drug-Eluting Balloon Study |
| Apr 13, 2012 |
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study |
| Mar 25, 2012 |
Medtronic Symplicity™ Renal Denervation System Demonstrates Significant and Sustained Blood Pressure Reduction Out to Three Years |
| Mar 24, 2012 |
Data Presented at ACC Reinforce Positive Clinical Outcomes for Patients Receiving Medtronic's CoreValve® System |
| Mar 24, 2012 |
Medtronic Resolute® Drug-Eluting Stent Delivers Durable Clinical Outcomes Through Two Years in Major Studies |
| Feb 17, 2012 |
Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease |
| Feb 13, 2012 |
Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity™ Renal Denervation System Across Multiple Conditions |
| Feb 8, 2012 |
Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study |
| Jan 24, 2012 |
Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial |
| Jan 17, 2012 |
Medtronic Endurant® II AAA Stent Graft System Launches Internationally With CE Mark |
| Nov 8, 2011 |
Medtronic Resolute® Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease |
| Nov 8, 2011 |
Study of Medtronic Endeavor® Drug-Eluting Stent Demonstrates Long-Term Advantages Over Taxus® DES |
| Nov 7, 2011 |
Medtronic CoreValve® System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation |
| Nov 4, 2011 |
Medtronic's Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011 |
| Aug 23, 2011 |
Medtronic Reports First Quarter Earnings |
| Jul 25, 2011 |
Medtronic
Resolute® Drug-Eluting Stent Shows Superiority to
Taxus ® DES
in Study of Patients with Coronary Artery Disease |
| Jun 18, 2011 |
VALOR
II Study Highlights Strengths of Valiant® Thoracic Stent Graft from
Medtronic |
| May 18, 2011 |
Medtronic
Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic
Patients with Heart Disease |
| May 17, 2011 |
Medtronic
CoreValve® Multi-Center Study Shows Rapid and Sustained Health-Related
Quality-Of-Life Improvements |
| May 16, 2011 |
Medtronic Advances Research on Peripheral Devices, Highlights Upcoming
Presentations |
| Apr 4, 2011 |
Medtronic
Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes
In Major Studies |
| Mar 28, 2011 |
Medtronic
to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent
at ACC.11 |
| Mar 14, 2011 |
Medtronic
Pledges $1 Million to Relief Efforts in Japan |
| Mar 3, 2011 |
Medtronic Seeking Long-Distance Runners Who Benefit From Medical
Technology |
| Feb 18, 2011 |
Largest Study of Medtronic CoreValve® System Confirms Positive Clinical Outcomes |
| Jan 18, 2011 |
Medtronic
Revises Design of CoreValve® U.S. Pivotal Trial |
| Jan 13, 2011 |
Medtronic
Completes Acquisition of Ardian |
| Dec 21, 2010 |
Landmark
Medtronic CoreValve® U.S. Clinical Trial Begins |
| Dec 21, 2010 |
Med-Tech
Advance for 'Silent Killer': FDA Approves Medtronic Device to
Fix Abdominal Aortic Aneurysms |
| Dec 9, 2010 |
Medtronic
CoreValve® System Gains CE Mark for New Subclavian Approach
to Transcatheter Aortic Valve Implantation |
| Nov 22, 2010 |
Medtronic
Signs Agreement to Acquire Ardian |
| Nov 19, 2010 |
Medtronic
Presents 30-Day Data On Valiant® Thoracic Stent Graft |
| Nov 19, 2010 |
Medtronic
Presents One-Year Data On Endurant® Stent Graft |
| Nov 17, 2010 |
Medtronic
Unveils EVARpro® Suite Of Services To Streamline Clinical
Use Of Aortic Stent Grafts |
| Nov 1, 2010 |
Medtronic
Receives FDA Approval of Talent Captivia® System for
Endovascular Treatment of Thoracic Aortic Aneurysms |
| Oct 15, 2010 |
Medtronic
Clinical Trial Receives FDA Approval to Evaluate New CoreValve® System
for Aortic Valve Implantation |
| Sep 28, 2010 |
Medtronic Advances Research on Drug-Eluting Balloons for Coronary
and Peripheral Artery Disease |
| Sep 22, 2010 |
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance
In Second 'All Comers' Study |
| Sep 20, 2010 |
Medtronic
Receives FDA Approval of Integrity® Coronary Stent |
| Sep 17, 2010 |
Medtronic Showcases Cardiovascular Devices at TCT 2010 |
| Sep 10, 2010 |
Medtronic Releases 2010 Corporate Citizenship Report |
| Sep 7, 2010 |
Medtronic
Gains CE Mark for Enhanced CoreValve® Delivery Catheter
System with AccuTrak Stability Layer |
| Aug 30, 2010 |
Medtronic Launches Resolute Integrity Drug-Eluting Stent In Europe |
| Aug 8, 2010 |
Medtronic
Opens Patient Care Centre in Beijing, China |
| Aug 6, 2010 |
Medtronic
Completes Enrollment in Clinical Study of Complete SE® (Self-Expanding)
Vascular Stent |
| Aug 5, 2010 |
First
Patient Treated with Medtronic’s Valiant® Thoracic
Stent Graft in Aortic Dissection Trial |
| May 26, 2010 |
Medtronic
CoreValve® System Shows Long-Term Efficacy and Durability
in Pivotal Trial |
| May 25, 2010 |
Multiple
European Clinical Registries Show Important Benefits of Medtronic
CoreValve® Transcatheter Aortic Valve System |
| May 25, 2010 |
Medtronic's
Resolute® Drug-Eluting Stent Matches Market-Leading
Rival in Large Head-To-Head Study |
| May 20, 2010 |
Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR |
| May 19, 2010 |
First
Patient Treated with Valiant® Thoracic Stent Graft in
Medtronic ’s “RESCUE” Clinical
Study |
| Apr 21, 2010 |
Medtronic
Receives FDA Approval for New Indication for Complete® SE Vascular
Stent |
| Mar 14, 2010 |
Medtronic's Endeavor Stent Continues to Demonstrate Compelling and
Consistent Long-Term Clinical Results |
| Mar 12, 2010 |
Medtronic
Starts International Study of CoreValve® Transcatheter
Aortic Valve System |
| Jan 25, 2010 |
Medtronic to Acquire Invatec and Affiliated Companies |
| Jan 25, 2010 |
Medtronic Receives FDA Approval for First Replacement Heart Valve
Implanted Without Surgery |
| Jan 21, 2010 |
Medtronic Pledges $1 Million to Haiti Earthquake Relief |
| Jan 15, 2010 |
Medtronic Pledges Over $250,000 to Haiti Earthquake Relief |
| Dec 8, 2009 |
Medtronic Hires Renowned Cardiologist as Vice President of Medical
Affairs for Coronary and Peripheral Business |
| Dec 2, 2009 |
Medtronic Names Michael J. Coyle as Executive Vice President and
Group President of Cardiology Businesses |
| Nov 25, 2009 |
Medtronic CEO William Hawkins to Speak at 21st Annual Piper Jaffray
Healthcare Conference |
| Nov 24, 2009 |
Medtronic
Second Quarter Revenue Increases 8% to $3.838 Billion; Raises
EPS Guidance for Current Fiscal Year |
| Nov 19, 2009 |
Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senate's
Revised Medical Device Industry Fee Proposal |
| Oct 13, 2009 |
Medtronic Starts Study of Interventional Erectile Dysfunction Therapy |
| Oct 5, 2009 |
2009
Medtronic Twin Cities Marathon “Global Heroes” Celebrate
Accomplishment |
| Sep 21, 2009 |
Medtronic’s Resolute® Drug-Eluting
Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term
Follow-Up |
| Sep 21, 2009 |
Endeavor® Stent Reduced Risk of Heart Attack/Cardiac Death by
48% at Three Years Compared to Taxus ® Stent
in Large Study |
| Sep 18, 2009 |
Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter
Heart Valves to Feature at TCT 2009 |
| Aug 25, 2009 |
Medtronic Reports First Quarter Revenue of $3.9 Billion |
| Aug 14, 2009 |
Medtronic
to Announce Financial Results for Its First Fiscal Quarter |
| Aug 6, 2009 |
Medtronic
Awarded $57 Million in Patent Dispute with AGA Medical Corporation |
| Jul 27, 2009 |
Medtronic and Abbott Laboratories Resolve Global Vascular Patent
Disputes |
| Jun 15, 2009 |
Talent Stent Graft Shows Durable Performance in Patients with Abdominal
Aortic Aneurysms |
| May 20, 2009 |
Medtronic’s
CoreValve Shows Subclavian Access Success in Patients Contraindicated
for Femoral Approach |
| May 19, 2009 |
Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating
Acute Coronary Syndrome |
| May 19, 2009 |
New Data From ENDEAVOR-II Challenges Conventional Wisdom on Drug-Eluting
Stents |
| May 18, 2009 |
Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit |
| May 15, 2009 |
New Data on Endeavor Stent's Long-Term Safety and Efficacy to Be
Featured at Interventional Cardiology Congress |
| May 14, 2009 |
Medtronic Completes Enrollment in International Post-Market Study
of Resolute Drug-Eluting Stent |
| Apr 27, 2009 |
Medtronic
Starts Enrollment in THRIVE, U.S. Post-Market Study of the Talent ™ Thoracic
Stent Graft |
| Apr 3, 2009 |
Medtronic Launches Driver Sprint RX Coronary Stent System Worldwide |
